Medical Condition News

RSS

Eating chocolates may lower stroke risk, but more research is needed

Eating chocolate may lower your risk of having a stroke, according to an analysis of available research that will be released today and presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010. Another study found that eating chocolate may lower the risk of death after suffering a stroke.

11 Feb 2010

Decline in breast cancer rates linked to race, ethnicity and economic background

Breast cancer rates are declining, but some groups have seen a more significant decline than others, with race, ethnicity and economic background playing a part.

11 Feb 2010

Mayo Clinic provides treatment options for aging skin

Age or liver spots -- These flat, brown areas, also called solar lentigos, typically occur on the hands, back and face. Using a topical retinoid -- often in conjunction with bleaching cream and a mild topical steroid -- may gradually fade an age spot.

11 Feb 2010

Chemical compound found in blood shows promise in preventing intractable form of heart failure

A chemical compound found normally in the blood has shown promise in treating and preventing an intractable form of heart failure in a mouse model of the disease, report researchers at the University of Illinois at Chicago College of Medicine.

11 Feb 2010

Cognitive behavioral therapy effective for insomnia and chronic pain

Cognitive behavioral therapy for insomnia significantly improved sleep for patients with chronic neck or back pain and also reduced the extent to which pain interfered with their daily functioning, according to a study by University of Rochester Medical Center researchers.

11 Feb 2010

3SBio submits application for Phase I clinical trial of NuPIAO to the Chinese SFDA

3SBio Inc., a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has submitted its application for a Phase I clinical trial for NuPIAO to the Chinese State Food and Drug Administration (SFDA).

11 Feb 2010

Study suggests obesity prevention efforts should begin much earlier

While many adults consider a chubby baby healthy, too many plump infants grow up to be obese teens, saddling them with Type-2 diabetes, elevated cholesterol and high blood pressure, according to an article published this month in the journal Clinical Pediatrics (published by SAGE).

11 Feb 2010

YM Biosciences to present JAK1/2 inhibiting small molecule and vascular disrupting agent data at Cancer Conference

YM BioSciences Inc., is presenting posters on its JAK1/2 inhibiting small molecule (CYT387) and on its novel vascular disrupting agent (CYT997) at the Lorne Cancer Conference in Lorne, Victoria, Australia. CYT387 is an oral JAK1/2 inhibitor, originating from the seminal discovery of JAK1 and JAK2 kinases by Dr. Andrew Wilks, the founder of Cytopia Limited, now YM Australia. CYT997 is an orally-available agent with dual mechanisms of vascular disruption and cytotoxicity and has the potential to be broadly active against a range of tumor types.

11 Feb 2010

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

11 Feb 2010

Biodel's VIAject insulin Phase 3 study results to be presented at international diabetes conference in Basel

Biodel, Inc. announced today that its chief executive officer, Dr. Sol Steiner, will present results from the company’s two Phase 3 studies with VIAject® ultra-rapid-acting recombinant human insulin in a platform presentation at the 3rd International Conference on Advanced Technologies and Treatments for Diabetes in Basel, Switzerland, on Friday, February 12, 2010, at 1pm central European time.

11 Feb 2010

Oral hygiene: Insights

Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.

11 Feb 2010

$NovaShunt initiates study to evaluate AFS for refractory ascites patients$

NovaShunt initiates study to evaluate AFS for refractory ascites patients

NovaShunt today announced the initiation of its pivotal multi- center clinical study named PIONEER, a Prospective, multi-center, open label, non-randomized study to Investigate the safety and perfOrmance of the Automated Fluid ShuNt in patiEnts with ascitEs and diuretic Resistance.

11 Feb 2010

Jamie Oliver's TED Prize wish: Foundation to transform junk food culture and reduce incidence of obesity

Celebrated British chef and food activist Jamie Oliver announced his 2010 TED Prize "wish to change the world" moments ago on the first day of the annual TED conference.

11 Feb 2010

Barley beta-glucan soluble fiber lowers cholesterol and reduces risk for coronary heart disease

According to statistics from the Centers for Disease Control and Prevention, heart disease continues to be the leading cause of death in the United States and is also a major cause of disability. But the good news is improving heart health can be as easy as making simple lifestyle changes like choosing foods with proven heart health-promoting attributes.

11 Feb 2010

New genetic 'hotspots' may help doctors devise therapies for bowel cancer patients

Cancer Research UK scientists have identified the frequency of new genetic 'hotspots' which could help doctors to tailor therapies to as many as 3,000 additional bowel cancer patients each year, according to research published in the British Journal of Cancer today.

11 Feb 2010

4SC AG announces the first treatment in Phase I clinical study of 4SC-205

4SC AG a drug discovery and development company focused on autoimmune and cancer indications, today announced the first treatment in a Phase I study evaluating 4SC-205, an oral Eg5 kinesin spindle protein inhibitor, in patients with solid tumours or malignant lymphomas.

11 Feb 2010

New campaign launched to bring attention to national asbestos problem

"Ban Asbestos Now," a campaign to build awareness of the continued use of asbestos in the United States, today launched the Ban Asbestos Now Video Search, asking students across the United States to use their creativity to draw national attention to the toxic, and often deadly, substance considered "the largest manmade public health crisis in history" according to the Asbestos Disease Awareness Organization (ADAO).

11 Feb 2010

Women's heart-health awareness: Educational campaigns with evidence-based prevention messages needed

Racial gaps exist in women's heart-health awareness, women's knowledge of heart attack warning signs requires attention and nearly half of women report they would not call 9-1-1 if they were having heart attack symptoms, according to new research published in Circulation: Cardiovascular Quality and Outcomes, a journal of the American Heart Association.

11 Feb 2010

Research study on epigenetic phenotypes published online in the Journal of Clinical Oncology

PrognosDx Health, Inc. announced today that in an independent research study published online in the Journal of Clinical Oncology, cellular levels of histone modifications define previously unrecognized subsets of patients with pancreatic cancer with distinct epigenetic phenotypes and clinical outcomes.

11 Feb 2010

'CARES by GSK' introduces oncology co-pay assistance program

GlaxoSmithKline today announced the launch of CARES by GSK, a comprehensive program that provides a single point of contact to GSK services and programs designed to improve access to GSK oncology and specialty medications. In addition to the comprehensive offerings that include specialty reimbursement services and free medicine, CARES by GSK now offers its first oncology co-pay assistance program to further help eligible patients with limited insurance coverage to have better access to GSK oral oncology and specialty medicines.

11 Feb 2010

Medical Condition News

Eating chocolates may lower stroke risk, but more research is needed

Decline in breast cancer rates linked to race, ethnicity and economic background

Mayo Clinic provides treatment options for aging skin

Chemical compound found in blood shows promise in preventing intractable form of heart failure

Cognitive behavioral therapy effective for insomnia and chronic pain

3SBio submits application for Phase I clinical trial of NuPIAO to the Chinese SFDA

Study suggests obesity prevention efforts should begin much earlier

YM Biosciences to present JAK1/2 inhibiting small molecule and vascular disrupting agent data at Cancer Conference

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Biodel's VIAject insulin Phase 3 study results to be presented at international diabetes conference in Basel

Oral hygiene: Insights

NovaShunt initiates study to evaluate AFS for refractory ascites patients

Jamie Oliver's TED Prize wish: Foundation to transform junk food culture and reduce incidence of obesity

Barley beta-glucan soluble fiber lowers cholesterol and reduces risk for coronary heart disease

New genetic 'hotspots' may help doctors devise therapies for bowel cancer patients

4SC AG announces the first treatment in Phase I clinical study of 4SC-205

New campaign launched to bring attention to national asbestos problem

Women's heart-health awareness: Educational campaigns with evidence-based prevention messages needed

Research study on epigenetic phenotypes published online in the Journal of Clinical Oncology

'CARES by GSK' introduces oncology co-pay assistance program

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News